IMP: Approval of the 2025 credit limit

Approval of the 2025 credit limit of Imexpharm Corporation as follows: 

HOSE

>   IMP: Approval of the purchase of D&O Insurance (04/04/2025)

>   CSM: BOD resolution dated April 03, 2025 (04/04/2025)

>   CNG: BOD resolution dated April 02, 2025 (04/04/2025)

>   FUEABVND: Basket of component securities 03 Apr 2025 (04/04/2025)

>   FUEVN100: Monthly report _ March 2025 (04/04/2025)

>   FUEVN100: NAV 02 Apr 2025 (04/04/2025)

>   FUEVN100: Basket of component securities 03 Apr 2025 (04/04/2025)

>   FUEVFVND: NAV 01 Apr 2025 (04/04/2025)

>   FUEVN100: Announcement after exchange trading 02 Apr 2025 (04/04/2025)

>   FUEVFVND: Basket of component securities 03 Apr 2025 (04/04/2025)